Follow
Gregory W. Carter
Title
Cited by
Cited by
Year
Cytoscape: a community-based framework for network modeling
S Killcoyne, GW Carter, J Smith, J Boyle
Protein networks and pathway analysis, 219-239, 2009
2452009
Light quarks in the instanton vacuum at finite baryon density
GW Carter, D Diakonov
Physical Review D 60 (1), 016004, 1999
2091999
Meta-analysis of the Alzheimer’s disease human brain transcriptome and functional dissection in mouse models
YW Wan, R Al-Ouran, CG Mangleburg, TM Perumal, TV Lee, K Allison, ...
Cell reports 32 (2), 2020
2072020
Comprehensive evaluation of the 5XFAD mouse model for preclinical testing applications: a MODEL-AD study
AL Oblak, PB Lin, KP Kotredes, RS Pandey, D Garceau, HM Williams, ...
Frontiers in aging neuroscience 13, 713726, 2021
1582021
Derivation of genetic interaction networks from quantitative phenotype data
BL Drees, V Thorsson, GW Carter, AW Rives, MZ Raymond, ...
Genome biology 6, 1-10, 2005
1552005
The tandem duplicator phenotype is a prevalent genome-wide cancer configuration driven by distinct gene mutations
F Menghi, FP Barthel, V Yadav, M Tang, B Ji, Z Tang, GW Carter, Y Ruan, ...
Cancer cell 34 (2), 197-210. e5, 2018
1462018
Neutrino propagation in color superconducting quark matter
GW Carter, S Reddy
Physical Review D 62 (10), 103002, 2000
1162000
Affinity-seq detects genome-wide PRDM9 binding sites and reveals the impact of prior chromatin modifications on mammalian recombination hotspot usage
M Walker, T Billings, CL Baker, N Powers, H Tian, RL Saxl, K Choi, ...
Epigenetics & chromatin 8, 1-13, 2015
862015
An effective Lagrangian with broken scale and chiral symmetry II: pion phenomenology
G Carter, PJ Ellis, S Rudaz
Nuclear Physics A 603 (3-4), 367-386, 1996
841996
Model organism development and evaluation for late‐onset Alzheimer's disease: MODEL‐AD
AL Oblak, S Forner, PR Territo, M Sasner, GW Carter, GR Howell, ...
Alzheimer's & Dementia: Translational Research & Clinical Interventions 6 (1 …, 2020
752020
Enhancing face validity of mouse models of Alzheimer’s disease with natural genetic variation
KD Onos, A Uyar, KJ Keezer, HM Jackson, C Preuss, CJ Acklin, ...
PLoS genetics 15 (5), e1008155, 2019
752019
HELLS and PRDM9 form a pioneer complex to open chromatin at meiotic recombination hot spots
C Spruce, S Dlamini, G Ananda, N Bronkema, H Tian, K Paigen, ...
Genes & development 34 (5-6), 398-412, 2020
632020
Forced tunneling and turning state explosion in pure Yang-Mills theory
DM Ostrovsky, GW Carter, EV Shuryak
Physical Review D 66 (3), 036004, 2002
632002
Prediction of phenotype and gene expression for combinations of mutations
GW Carter, S Prinz, C Neou, JP Shelby, B Marzolf, V Thorsson, T Galitski
Molecular systems biology 3 (1), 96, 2007
612007
The nonperturbative color Meissner effect in a two-flavor color superconductor
GW Carter, D Diakonov
Nuclear Physics B 582 (1-3), 571-590, 2000
592000
Natural genetic variation determines microglia heterogeneity in wild-derived mouse models of Alzheimer’s disease
HS Yang, KD Onos, K Choi, KJ Keezer, DA Skelly, GW Carter, GR Howell
Cell Reports 34 (6), 2021
582021
Biological information as set-based complexity
DJ Galas, M Nykter, GW Carter, ND Price, I Shmulevich
IEEE Transactions on Information Theory 56 (2), 667-677, 2010
582010
Epistatic networks jointly influence phenotypes related to metabolic disease and gene expression in diversity outbred mice
AL Tyler, B Ji, DM Gatti, SC Munger, GA Churchill, KL Svenson, ...
Genetics 206 (2), 621-639, 2017
482017
Clustering of transcriptional profiles identifies changes to insulin signaling as an early event in a mouse model of Alzheimer’s disease
HM Jackson, I Soto, LC Graham, GW Carter, GR Howell
BMC genomics 14, 1-12, 2013
482013
A novel systems biology approach to evaluate mouse models of late-onset Alzheimer’s disease
C Preuss, R Pandey, E Piazza, A Fine, A Uyar, T Perumal, D Garceau, ...
Molecular neurodegeneration 15, 1-16, 2020
462020
The system can't perform the operation now. Try again later.
Articles 1–20